Trial reportPain management2025
Efficacy of temporo-parietal fascia trigger point release in the management of tension-type headache: a single-blinded RCT.
Trial report in Pain management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe study aimed to investigate the effects of Temporoparietal Fascia trigger point release in subjects with Tension Type Headache (TTH) and on decreasing pain intensity and head and neck disability.
methods40 subjects were randomly assigned to either Group 1 (intervention group) or Group 2 (control group) and received treatment for 10 days. Outcome measures, including the Visual Analog Scale (VAS) for pain intensity, Neck Disability Index (NDI) for neck disability, Headache Disability Inventory (HDI) for headache disability, and Pressure Pain Threshold (PPT) were used. Assessments were conducted in both groups before and after the 10-day intervention period.
resultBoth groups exhibited statistically significant improvements in pain intensity, neck and headache disability, and pressure pain threshold after 10 days of intervention (
conclusionThe study concluded that Myofascial trigger points (MTrPs) release is notably effective in pain reduction, as evidenced by greater clinical improvement in the intervention group compared to the control group. Both groups experienced similar benefits in reducing head and neck-related disabilities and increasing pain pressure thresholds. CLINICAL
trial registrationwww.ctri.nic.in, identifier: CTRI/2023/06/054085.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.